THE SHORT VERSION

  • In a 2013 study of healthy adults, researchers found 356 different peptides in the gut after casein and 146 after whey. These proteins start with different amino acid sequences, so digestion produces different fragments.
  • Some fragments have been studied for effects on gut movement, bacteria, and immune cells. The activity examples here come from rats, laboratory tests, and cultured cells. They do not establish effects in people drinking a protein beverage.
  • The takeaway: being present in the gut is not the same as changing how the gut works. Each proposed effect needs to be tested in people.
  • The question to ask: where would the fragment have to act, and has that been tested with the preparation and dose in question?

Protein digestion is often told as a short trip: a drink goes in and amino acids show up in the blood. There is a stretch in the middle that this account skips.

For a while, proteins are still being cut apart. The pieces, called peptides, share space with the gut lining and the microbes that live there.1,2

Some peptides have drawn interest because they can interact with receptors, bacteria, or immune cells. Whey and casein start with different amino acid sequences, so they can leave different fragments behind. Which ones are present also changes as digestion goes on.1,2

To understand a proposed effect, follow the fragment to the place where it would have to act. Finding it in the gut is one step. Showing that it reaches a target and changes how that target behaves takes more evidence.2

What researchers found inside the gut

In a 2013 study, researchers collected gut contents for six hours after healthy adults consumed 30 grams of casein or whey. Seven people received casein and six received whey.1

The team identified 356 peptides after casein and 146 after whey, with different patterns of release. Many of the casein peptides came from beta-casein, a type of casein. They included fragments called beta-casomorphins.1

The experiment showed that particular sequences appeared during human digestion. It did not measure their effects on bowel movements, digestive comfort, or immune protection. Those are separate outcomes, and each needs its own measurement.1

The authors noted that the conditions under which these peptides would be active in people still needed to be understood.1

A fragment may not stay intact

In a laboratory experiment, researchers exposed synthetic beta-casomorphin-7 to human digestive juices, then to enzyme preparations from pig gut tissue. The preparations came from the brush border, the enzyme-rich surface of the gut lining.3

About 79% of the peptide was broken down after four hours of the brush-border stage. Roughly 5% remained intact after 24 hours. The experiment did not establish whether that small intact fraction would enter the bloodstream in people.3

Casein fragments and the movement of the gut

Beta-casomorphins are studied for activity at opioid receptors, cell targets involved in regulating gut movement. Researchers have therefore asked whether these casein fragments can change how quickly food passes through the gut.4

In a 1990 rat experiment, the stomach emptied more slowly after casein than after whey. Movement through the gut, called gastrointestinal transit, was also slower.4

Before feeding, some rats received naloxone, a drug that blocks opioid receptors. This partly reversed the difference in stomach emptying and removed the difference in gut transit.4

The findings supported a possible role for opioid signaling under those experimental conditions. They did not show how strongly that mechanism works in people drinking a particular finished beverage.4

Casein can also form curds in the stomach, a physical process that influences digestion. Curd formation and a peptide acting at a receptor are different mechanisms. Slower movement alone cannot tell us how much each contributes.2,4

A whey protein can release an antibacterial fragment

Lactoferrin, a protein in the whey part of milk, can release a peptide called lactoferricin when the digestive enzyme pepsin cuts it. Researchers have studied how this fragment interacts with bacteria.2,5

In a 1993 laboratory study, purified bovine lactoferrin, the form from cow’s milk, and its lactoferricin fragment both damaged the outer membranes of the Gram-negative bacteria tested. Gram-negative describes a group of bacteria with a particular cell-wall structure.5

Only the fragment consistently killed bacteria under the tested conditions. The intact protein was at most bacteriostatic, meaning it slowed growth without killing. The fragment’s activity also varied with the levels of calcium, magnesium, and iron present.5

These results describe activity against particular bacteria in controlled experiments. To act in the gut, the fragment would still need to remain available at a high enough concentration where those bacteria are found.2,5

Killing bacteria in a laboratory test does not show a beneficial change in someone’s gut microbiome, the community of microbes living there.2,5

Immune cells raise another question about access

Milk-derived peptides have also been studied for effects on cytokines, signaling molecules that immune cells use to communicate.6

A 2020 study tested casein-derived peptides and peptide mixtures from fermentation on cultured human monocytes, a type of immune cell. Certain peptides stimulated production of interleukin-10, or IL-10, a cytokine involved in regulating immune responses.6

The cells were exposed directly to the test preparations. The experiment did not show that a protein drink delivers those peptides to immune cells in the gut wall or reduces inflammation in people.6

It identified cell responses worth investigating under conditions that more closely reflect what happens in the body.6

Possible sites of direct peptide action. The examples come from separate bacterial, rat, and cell-culture experiments.4,5,6 They do not establish effects in the human gut or distant organs.

Possible sites of direct peptide action. The examples come from separate bacterial, rat, and cell-culture experiments.4,5,6 They do not establish effects in the human gut or distant organs.

Where an effect happens changes the evidence needed

An interaction with bacteria in the gut contents can happen without the peptide entering the bloodstream. An interaction with receptors or immune cells in the gut wall requires access to those targets.2

For a peptide to act directly in a distant organ, more evidence is needed: that it survives digestion, is absorbed, and reaches that tissue in an effective amount.2

That is why “gut health” is too broad a phrase for a peptide experiment. Changes in transit, bacterial growth, and cytokine production answer different questions. Each finding has to stay attached to the preparation, dose, and experimental system in which it was seen.

Related reading

References

Educational content. The Fountain is written to explain, not to make health claims about any product. This article summarizes published peer-reviewed research. Nothing here is medical advice.

  1. Boutrou R, Gaudichon C, Dupont D, et al. Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans. American Journal of Clinical Nutrition. 2013;97(6):1314–1323. https://doi.org/10.3945/ajcn.112.055202
  2. Auestad N, Layman DK. Dairy bioactive proteins and peptides: a narrative review. Nutrition Reviews. 2021;79(Suppl 2):36–47. https://doi.org/10.1093/nutrit/nuab097
  3. Asledottir T, Picariello G, Mamone G, et al. Degradation of β-casomorphin-7 through in vitro gastrointestinal and jejunal brush border membrane digestion. Journal of Dairy Science. 2019;102(10):8622–8629. https://doi.org/10.3168/jds.2019-16771
  4. Daniel H, Vohwinkel M, Rehner G. Effect of casein and beta-casomorphins on gastrointestinal motility in rats. Journal of Nutrition. 1990;120(3):252–257. https://doi.org/10.1093/jn/120.3.252
  5. Yamauchi K, Tomita M, Giehl TJ, Ellison RT III. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infection and Immunity. 1993;61(2):719–728. https://doi.org/10.1128/iai.61.2.719-728.1993
  6. Adams C, Sawh F, Green-Johnson JM, Jones Taggart H, Strap JL. Characterization of casein-derived peptide bioactivity: differential effects on angiotensin-converting enzyme inhibition and cytokine and nitric oxide production. Journal of Dairy Science. 2020;103(7):5805–5815. https://doi.org/10.3168/jds.2019-17976